Astera Labs, Inc. $ALAB Shares Sold by Focus Partners Wealth

Focus Partners Wealth cut its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 0.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 322,325 shares of the company’s stock after selling 2,918 shares during the period. Focus Partners Wealth’s holdings in Astera Labs were worth $55,301,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. Lido Advisors LLC lifted its holdings in Astera Labs by 0.5% in the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after acquiring an additional 57 shares during the last quarter. Perigon Wealth Management LLC lifted its holdings in Astera Labs by 6.2% in the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock valued at $208,000 after acquiring an additional 73 shares during the last quarter. Clearstead Advisors LLC lifted its holdings in Astera Labs by 13.6% in the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock valued at $125,000 after acquiring an additional 76 shares during the last quarter. Sound Income Strategies LLC lifted its holdings in Astera Labs by 9.2% in the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock valued at $164,000 after acquiring an additional 76 shares during the last quarter. Finally, Venturi Wealth Management LLC lifted its holdings in Astera Labs by 2.6% in the fourth quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock valued at $546,000 after acquiring an additional 84 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Astera Labs

In other news, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the sale, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. This represents a 7.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the company’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the sale, the director directly owned 75,688 shares in the company, valued at $26,882,106.96. This represents a 11.67% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 2,161,256 shares of company stock valued at $459,844,296. Insiders own 10.40% of the company’s stock.

Astera Labs Trading Up 6.0%

Astera Labs stock opened at $389.20 on Tuesday. Astera Labs, Inc. has a twelve month low of $84.78 and a twelve month high of $398.13. The stock’s fifty day simple moving average is $242.61 and its 200-day simple moving average is $180.88. The firm has a market capitalization of $66.71 billion, a P/E ratio of 262.97, a P/E/G ratio of 4.86 and a beta of 3.94.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter in the prior year, the company earned $0.33 earnings per share. The company’s revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Sell-side analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on ALAB. Evercore reiterated an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. Jefferies Financial Group reiterated a “buy” rating and issued a $270.00 price objective on shares of Astera Labs in a report on Wednesday, May 6th. Royal Bank Of Canada upped their price objective on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a report on Wednesday, May 6th. UBS Group began coverage on Astera Labs in a report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price objective on the stock. Finally, TD Cowen upped their price objective on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a report on Wednesday, May 6th. Twelve research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.